ALLMedicine™ Ulcerative Colitis Center
Research & Reviews 9,762 results
https://doi.org/10.1097/MPG.0000000000003545
Journal of Pediatric Gastroenterology and Nutrition; El-Matary W, Witt J et. al.
Jun 28th, 2022 - Data on pediatric inflammatory bowel disease (IBD)-associated indirect and out of pocket costs are limited. We aimed to estimate indirect (lost work hours and productivity) and out of pocket (OOP) pediatric IBD-associated costs in Canada. In a nat...
https://doi.org/10.1053/j.gastro.2022.06.052
Gastroenterology Nguyen NH, Solitano V et. al.
Jun 27th, 2022 - Proactive therapeutic drug monitoring (TDM) has been proposed to improve outcomes in patients with inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF)α antagonists. We conducted a systematic review and meta-analysis of random...
https://doi.org/10.1265/ehpm.22-00041
Environmental Health and Preventive Medicine; Shin YK, Kwon S et. al.
Jun 27th, 2022 - Ulcerative colitis (UC) is related to stress, but few studies have evaluated the influence of stress on factors affecting colon contractility in rats with UC. Also, there have been no studies investigating beneficial effects of linalyl acetate (LA...
https://doi.org/10.1016/j.transproceed.2022.03.041
Transplantation Proceedings; Trevizoli NC, Obeid EJ et. al.
Jun 27th, 2022 - The association between ulcerative colitis (UC) and primary sclerosing cholangitis has been described for several years and can be classified as having a distinct disease phenotype from inflammatory bowel diseases (IBD). The simultaneous occurrenc...
https://doi.org/10.1007/s10620-022-07598-2 10.1038/nature10673 10.1038/nrc3239 10.1016/j.ccell.2015.03.001 10.1093/annonc/mdv182 10.1038/nrclinonc.2016.58 10.1093/annonc/mdv623 10.1186/s12885-019-6150-y 10.1016/S1470-2045(15)70076-8 10.1016/j.jtho.2017.08.022 10.1056/NEJMoa1412082 10.1200/JCO.2015.66.1389 10.1056/NEJMoa1003466 10.1097/MCG.0b013e31828f1d51 10.3109/0284186X.2012.682630 10.1200/JCO.2005.04.5716 10.1056/NEJMc1509660 10.1016/j.cgh.2016.09.017 10.12659/AJCR.908570 10.1016/j.it.2019.04.002 10.1053/j.semdp.2019.07.009 10.3389/fcvm.2019.00003 10.1016/j.autrev.2014.01.028 10.3748/wjg.14.7302 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 10.1093/ecco-jcc/jjv210 10.1111/joim.12744 10.1007/s00262-018-2134-z 10.1038/s41379-018-0013-y 10.1097/PAS.0b013e31817150e3 10.1111/cup.13454
Digestive Diseases and Sciences; Takahashi Y, Nagaya T et. al.
Jun 25th, 2022 - Immune checkpoint inhibitors (ICPIs) have revolutionized cancer therapy, although immune-related adverse events (irAEs) remain a serious issue. The clinical characteristics of colitis induced by ICPIs are very similar to inflammatory bowel disease...
Guidelines 26 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.
Oct 22nd, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology
Mar 29th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.
Mar 15th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175923
Gastroenterology Feuerstein JD, Isaacs KL et. al.
Jan 17th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|therapeutic use,standards,diagnosis,immunology,therapy,diagnostic imaging,immunology,p...
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.
Oct 30th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,
Drugs 431 results see all →
Clinicaltrials.gov 1,207 results
https://clinicaltrials.gov/ct2/show/NCT00001184
Jun 24th, 2022 - This natural history protocol provides for the evaluation of patients with idiopathic inflammatory bowel diseases (ulcerative colitis, Crohn's disease, IBD associated with immunodeficiency and genetic diseases such as chronic granulomatous disease...
https://clinicaltrials.gov/ct2/show/NCT04314375
Jun 24th, 2022 - This is a randomized, double-blind, placebo-controlled, multicenter, study to evaluate the efficacy, safety, and pharmacokinetics (PK) of budesonide extended-release tablets for the induction of remission in pediatric subjects, with active, mild t...
https://clinicaltrials.gov/ct2/show/NCT03278912
Jun 24th, 2022 - Over 1 million people suffer from IBD in the United States. Although the exact pathogenesis is unclear, IBD results from an inappropriate inflammatory response to intestinal microbes which is influenced by the environment in a genetically suscepti...
https://clinicaltrials.gov/ct2/show/NCT03983837
Jun 24th, 2022 - Chronic granulomatous disease (CGD) is a rare genetic immune disorder that results in recurrent and severe infections, and inflammatory dysregulation. For almost 50% of patients with CGD, this inflammation causes severe inflammatory bowel disease ...
https://clinicaltrials.gov/ct2/show/NCT02770040
Jun 24th, 2022 - The purpose of this study is to identify whether an Accelerated or Intensified Infliximab induction regimen is superior to Standard induction in Acute Severe Ulcerative Colitis in an open label multi-centre randomised controlled trial.
News 1,197 results
https://www.mdedge.com/internalmedicine/article/255762/gastroenterology/gaps-ulcerative-colitis-care-expectations
Thomas R. Collins
Jun 24th, 2022 - Gaps in priorities and perceptions about managing disease exist between physicians and patients with ulcerative colitis (UC), according to survey findings recently published in Therapeutic Advances in Gastroenterology. The results – which come fro.
https://www.mdedge.com/uc-crohn-disease-challenge-center/article/255486/uc-crohn-disease/diarrhea-and-weight-loss
Jun 16th, 2022 - On the basis of the patient's presentation and history, this is probably a case of Crohn disease. Considering that the age of onset of Crohn disease has a bimodal distribution, this case is representative of late-onset disease.
https://www.medscape.com/viewarticle/974967
Jun 8th, 2022 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. I've just returned back from San Diego, where Digestive Disease ...
https://www.mdedge.com/neurology/article/255224/parkinsons-disease/blood-based-assay-may-offer-new-way-diagnosing
Will Pass
Jun 6th, 2022 - A novel blood-based assay could one day be used to diagnose Parkinson’s disease and possibly other chronic inflammatory conditions, according to investigators. In addition to being highly accurate, the assay, which detects changes in expression of.
https://www.medscape.com/viewarticle/975130
Jun 6th, 2022 - A novel blood-based assay could one day be used to diagnose Parkinson's disease and possibly other chronic inflammatory conditions, according to investigators. In addition to being highly accurate, the assay, which detects changes in expression of...